M&A

Pfizer steps up pressure on AstraZeneca with fresh approach
FT.com
Mon, 04/28/14 - 08:46 am
Pfizer
M&A
AstraZeneca
Forest Labs to buy fellow drugmaker Furiex Pharma in deal worth about $1.5 billion.
Yahoo/AP
Mon, 04/28/14 - 08:43 am
Forest Labs
M&A
Furiex Pharmaceuticals
AstraZeneca vulnerable after recent rumours
Proactive Investors, UK
Sat, 04/26/14 - 11:02 am
AstraZeneca
M&A
Mylan Said to Raise Offer for Swedish Drugmaker Meda
Bloomberg
Fri, 04/25/14 - 03:27 pm
M&A
Mylan
Meda
3 Questions About a Big Pharma Megamerger
Motley Fool
Fri, 04/25/14 - 03:24 pm
M&A
Pfizer
AstraZeneca
Big Pharma
palbociclib
Allergan made a pass at Shire before Valeant came calling
Fierce Biotech
Fri, 04/25/14 - 09:53 am
Valeant Pharmaceuticals
M&A
Allergan
Shire
Allergan can do better than Valeant offer, investor says
Mass Device
Fri, 04/25/14 - 09:18 am
Valeant Pharmaceuticals
Allergan
M&A
Prestige Brands to buy Insight Pharma for $750 million
Marketwatch
Fri, 04/25/14 - 08:13 am
Prestige Brands
M&A
Insight Pharma
Allergan sales force key to Valeant chief's plans for post-merger growth
Fierce Pharma Marketing
Thu, 04/24/14 - 11:32 am
Allergan
Valeant Pharmaceuticals
drug reps
M&A
AstraZeneca flags cancer advances, silent on Pfizer bid talk
Yahoo/Reuters
Thu, 04/24/14 - 11:23 am
Pfizer
AstraZeneca
M&A
cancer
earnings
[video]Is This Struggling Drugmaker Worth $100 Billion?
Motley Fool
Thu, 04/24/14 - 09:52 am
Pfizer
M&A
AstraZeneca
GSK's R&D staff hit with trade rumors spurred by Novartis' cancer pact
Fierce Biotech
Thu, 04/24/14 - 08:22 am
GSK
R&D
Novartis
M&A
[video] Why Is the Drug Industry in a Deal Frenzy?
Bloomberg
Thu, 04/24/14 - 07:31 am
M&A
Novartis
Valeant Pharmaceuticals
GSK
Eli Lilly
Allergan
AstraZeneca CEO: M&A 'often disruptive;' company posts higher revenues, but declining profits
CNBC
Thu, 04/24/14 - 07:20 am
Pharma CEOs
Pfizer
Pascal Soriot
M&A
earnings
AstraZeneca
Allergan poison pill presages a battle against Valeant's $47B takeover
Fierce Pharma
Wed, 04/23/14 - 12:48 pm
poison pill
Valeant Pharmaceuticals
M&A
Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
Motley Fool
Wed, 04/23/14 - 10:34 am
Valeant Pharmaceuticals
Allergan
M&A
medical aesthetics
The Novartis-Glaxo-Lilly Swap’s Downside: Less Research
Bloomberg/Businessweek
Wed, 04/23/14 - 08:42 am
Novartis
Eli Lilly
R&D
GSK
M&A
Novartis, Valeant bids herald new deal-making era for pharma
Yahoo/Reuters
Wed, 04/23/14 - 08:30 am
Novartis
Valeant Pharmaceuticals
GSK
Eli Lilly
M&A
Allergan
Is This a Good Deal for Novartis AG and GlaxoSmithKline plc?
Motley Fool
Tue, 04/22/14 - 04:20 pm
Novartis
GSK
M&A
GlaxoSmithKline CEO says established products portfolio "not part of our future"
First Word Pharma
Tue, 04/22/14 - 10:10 am
GSK
Andrew Witty
Novartis
Pharma CEOs
M&A
vaccines

Pages